Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use

Sophie I. Mavrogeni; George D. Kitas; Theodoros Dimitroulas; Petros P. Sfikakis; Philip Seo; Sherine Gabriel; Amit R. Patel; Luna Gargani; Stefano Bombardieri; Marco Matucci-Cerinic; Massimo Lombardi; Alessia Pepe; Anthony H. Aletras; Genovefa Kolovou; Tomasz Miszalski; Piet van Riel; AnneGrete Semb; Miguel Angel Gonzalez-Gay; Patrick Dessein; George Karpouzas; Valentina Puntman; Eike Nagel; Konstantinos Bratis; Georgia Karabela; Efthymios Stavropoulos; Gikas Katsifis; Loukia Koutsogeorgopoulou; Albert van Rossum; Frank Rademakers; Gerald Pohost; Joao A.C. Lima

doi:10.1016/j.ijcard.2016.04.158

Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use

Sophie I. Mavrogeni, George D. Kitas, Theodoros Dimitroulas, Petros P. Sfikakis, Philip Seo, Sherine Gabriel, Amit R. Patel, Luna Gargani, Stefano Bombardieri, Marco Matucci-Cerinic, Massimo Lombardi, Alessia Pepe, Anthony H. Aletras, Genovefa Kolovou, Tomasz Miszalski, Piet van Riel, AnneGrete Semb, Miguel Angel Gonzalez-Gay, Patrick Dessein, George KarpouzasValentina Puntman, Eike Nagel, Konstantinos Bratis, Georgia Karabela, Efthymios Stavropoulos, Gikas Katsifis, Loukia Koutsogeorgopoulou, Albert van Rossum, Frank Rademakers, Gerald Pohost, Joao A.C. Lima

Biomedical Engineering Department

Research output: Contribution to journal › Article › peer-review

99 Citations (Scopus)

498 Downloads (Pure)

Abstract

Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.

Original language	English
Journal	International Journal of Cardiology
Early online date	27 Apr 2016
DOIs	https://doi.org/10.1016/j.ijcard.2016.04.158
Publication status	E-pub ahead of print - 27 Apr 2016

Keywords

Rheumatic diseases
Cardiovascular magnetic resonance imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijcard.2016.04.158

1-s2.0-S0167527316308555-mainAccepted author manuscript, 1.76 MBLicence: CC BY-NC-ND

Cite this

Mavrogeni, S. I., Kitas, G. D., Dimitroulas, T., Sfikakis, P. P., Seo, P., Gabriel, S., Patel, A. R., Gargani, L., Bombardieri, S., Matucci-Cerinic, M., Lombardi, M., Pepe, A., Aletras, A. H., Kolovou, G., Miszalski, T., van Riel, P., Semb, A., Gonzalez-Gay, M. A., Dessein, P., ... Lima, J. A. C. (2016). Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2016.04.158

@article{9fbe009b489040b7966636377cbe830d,

title = "Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use",

abstract = "Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.",

keywords = "Rheumatic diseases, Cardiovascular magnetic resonance imaging",

author = "Mavrogeni, {Sophie I.} and Kitas, {George D.} and Theodoros Dimitroulas and Sfikakis, {Petros P.} and Philip Seo and Sherine Gabriel and Patel, {Amit R.} and Luna Gargani and Stefano Bombardieri and Marco Matucci-Cerinic and Massimo Lombardi and Alessia Pepe and Aletras, {Anthony H.} and Genovefa Kolovou and Tomasz Miszalski and {van Riel}, Piet and AnneGrete Semb and Gonzalez-Gay, {Miguel Angel} and Patrick Dessein and George Karpouzas and Valentina Puntman and Eike Nagel and Konstantinos Bratis and Georgia Karabela and Efthymios Stavropoulos and Gikas Katsifis and Loukia Koutsogeorgopoulou and {van Rossum}, Albert and Frank Rademakers and Gerald Pohost and Lima, {Joao A.C.}",

year = "2016",

month = apr,

day = "27",

doi = "10.1016/j.ijcard.2016.04.158",

language = "English",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

Mavrogeni, SI, Kitas, GD, Dimitroulas, T, Sfikakis, PP, Seo, P, Gabriel, S, Patel, AR, Gargani, L, Bombardieri, S, Matucci-Cerinic, M, Lombardi, M, Pepe, A, Aletras, AH, Kolovou, G, Miszalski, T, van Riel, P, Semb, A, Gonzalez-Gay, MA, Dessein, P, Karpouzas, G, Puntman, V, Nagel, E , Bratis, K, Karabela, G, Stavropoulos, E, Katsifis, G, Koutsogeorgopoulou, L, van Rossum, A, Rademakers, F, Pohost, G & Lima, JAC 2016, 'Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use', International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2016.04.158

TY - JOUR

T1 - Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use

AU - Mavrogeni, Sophie I.

AU - Kitas, George D.

AU - Dimitroulas, Theodoros

AU - Sfikakis, Petros P.

AU - Seo, Philip

AU - Gabriel, Sherine

AU - Patel, Amit R.

AU - Gargani, Luna

AU - Bombardieri, Stefano

AU - Matucci-Cerinic, Marco

AU - Lombardi, Massimo

AU - Pepe, Alessia

AU - Aletras, Anthony H.

AU - Kolovou, Genovefa

AU - Miszalski, Tomasz

AU - van Riel, Piet

AU - Semb, AnneGrete

AU - Gonzalez-Gay, Miguel Angel

AU - Dessein, Patrick

AU - Karpouzas, George

AU - Puntman, Valentina

AU - Nagel, Eike

AU - Bratis, Konstantinos

AU - Karabela, Georgia

AU - Stavropoulos, Efthymios

AU - Katsifis, Gikas

AU - Koutsogeorgopoulou, Loukia

AU - van Rossum, Albert

AU - Rademakers, Frank

AU - Pohost, Gerald

AU - Lima, Joao A.C.

PY - 2016/4/27

Y1 - 2016/4/27

N2 - Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.

AB - Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.

KW - Rheumatic diseases

KW - Cardiovascular magnetic resonance imaging

U2 - 10.1016/j.ijcard.2016.04.158

DO - 10.1016/j.ijcard.2016.04.158

M3 - Article

SN - 0167-5273

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this